Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer

Accumulating evidence indicates a link between diabetes and cancer. Selective estrogen receptor modulators (SERMs) may increase diabetes risk via antiestrogen effects. This study investigated incident diabetes risk of SERM treatment and its effects on metastatic cancer and death prevention in breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yeo-Jin, Bak, Keunhyeong, Yeo, Yoon, Choi, Yongwon, Shin, Sooyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472249/
https://www.ncbi.nlm.nih.gov/pubmed/34577625
http://dx.doi.org/10.3390/ph14090925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472249/
https://www.ncbi.nlm.nih.gov/pubmed/34577625
http://dx.doi.org/10.3390/ph14090925

Ejemplares similares